Addressing and Understanding the Significant Developments and Latest Decisions on Patent Eligibility
Significant decisions in patent cases from the Supreme Court, Federal Circuit and the Patent Trial and Appeal Board (PTAB) continue to shape the patent litigation landscape. Additionally, the United States Patent and Trademark Office (USPTO) occasionally updates its patent eligibility guidance to illustrate how patent examiners should evaluate claims for patent subject matter eligibility under 35 U.S.C. § 101. In this ever-evolving patent eligibility landscape, it is important for patent counsel to keep abreast and understand the noteworthy developments surrounding this remarkable topic.
In this LIVE Webcast, a panel of distinguished professionals and thought leaders will discuss the latest key judicial developments, including Supreme Court, Federal Circuit and PTAB decisions related to patent eligibility. They will provide insights into the impact of these developments and offer best practices for handling patent cases.
Key topics include:
- Subject Matter Eligibility Update
- Latest USPTO Patent-Eligibility Guidance
- Key Judicial Developments
- Supreme Court, Federal Circuit and PTAB Decisions
- Impact to Future Cases
- Roadmap for Practitioners
Eli Mazour, Attorney
Harrity & Harrity, LLP
- Trends (& decisions) for patent eligibility of software-related patents
- Related trends at the PTAB
- Patent drafting & prosecution strategies for dealing with these trends
Dr. Andrej Barbic, Senior Patent Counsel
Proskauer Rose LLP
- Methodology of claims
- Recent cases after Ariosa
- Steps to take
Who Should Attend:
- Patent Attorneys
- Intellectual Property Lawyers
- Patent Consultants
- Patent Licensing Attorneys
- Patent Litigators
- Patent Holders
- Private Companies
- Other Related Professionals
Eli Mazour recently started the online series Clause 8 (https://www.clause8.tv/), which features video and podcast interviews with the most interesting members of the IP community.
Eli’s practice focuses on helping large technology companies build valuable, high-quality patent portfolios in an efficient manner. Eli has extensive experience in all aspects of patent prosecution, including preparing and prosecuting hundreds of patent applications related to computer software, Internet and e-commerce, telecommunications, networking devices, electronic consumer products, medical devices, and military technology.
Eli has particular expertise in developing and implementing innovative patent prosecution strategies for reaching favorable results at the U.S. Patent and Trademark Office. He also helps clients evaluate existing patent portfolios, identify strategic areas for patenting, and create processes for harvesting disclosures of patentable inventions.
Eli Mazour recently started the online series Clause 8 (https://www.clause8.tv/), which features video and podcast interviews with the most interesting …
Andrej Barbic, Ph.D. is senior patent counsel in Proskauer’s Life Sciences Patent practice, and represents numerous small and large multinational companies in the biotech and pharmaceutical industries. His practice focuses on U.S. and foreign patent counseling and portfolio development, post-grant proceedings in the USPTO and patent litigation in the pharmaceutical industry. Dr. Barbic regularly counsels clients on patent strategy related to small molecules, pharmaceutical formulations, rational drug design, protein engineering, genome editing, DNA sequencing, diagnostics and other areas of biotechnology in an effort to build robust patent portfolios that can stand up to challenges in the USPTO after grant. He currently serves as the co-chair of Contested Matters Committee of the Boston Patent Law Association. He earned his Ph.D. in Biophysical Chemistry from Yale University, and his J.D. cum laude from Suffolk University Law School.
Andrej Barbic, Ph.D. is senior patent counsel in Proskauer’s Life Sciences Patent practice, and represents numerous small and large multinational …
Print and review course materials
Method of Presentation:
Experience in patent law
NASBA Field of Study:
Business Law - Technical
NY Category of CLE Credit:
Areas of Professional Practice
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
About Harrity & Harrity, LLP
Harrity & Harrity is an IP boutique that has been specializing in the preparation and prosecution of electrical and mechanical patent applications since 1999. Our services include patent preparation and prosecution, patent opinions, patent reexamination, patent reissue, patent quality support, patent analytics, and patent preparation and prosecution training.
Quality is the area that truly separates us from our peers. We pride ourselves on consistently delivering high quality through the use of a thorough second attorney review process and a uniform writing style that is tailored to our clients’ needs. At Harrity & Harrity, we say that We Patented Quality®, and the second attorney review process and the uniform writing style ensure that we provide our clients with the highest quality patent preparation and prosecution services each and every time.
About Proskauer Rose LLP
Proskauer’s Life Sciences Patent Practice
Proskauer’s collaborative Life Sciences Patent practice focuses on partnering with leading biologics, pharmaceutical, biotechnology, and medical device clients to meet their business objectives by developing and executing market exclusivity and freedom-to-operate strategies. These comprehensive strategies draw from our deep knowledge of and extensive experience with patent litigation, contested patent office proceedings, FDA regulations, patent prosecution and patent transactions, including licenses and assignments. Our deep knowledge of the most important therapeutic areas, such as immunology, oncology and neurology, has allowed us to successfully represent our clients in the courtroom as well as the patent office, including against some of the industry’s most aggressive companies and institutions. Proskauer lawyers a wealth of experience in post-grant challenges and have achieved impressive results in inter partes review (IPR) decisions for their life sciences clients.